Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Cencora (COR) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareCOR

Latest price · Nov 20, 2026 $343.02 +0.5% on the day · -4.7% over 12 months 52-week range $251.67 – $372.53
Get COR alerts
Open-market purchases2 insiders$2.3M · last 12 months
Insiders selling5last 12 months
Reported sales$13.5M10 of 15 recent sales pre-planned (10b5-1)
In 15 seconds

Some insider buying ($2.3M), but sales were much larger ($13.5M) over the same 12 months.

Past insider buys here: 3 of 3 beat the S&P 500 over the next 90 days (small sample). See each one ↓

Label: Net selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
  • Next earnings expected around Feb 3, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Latest open-market trade

Sale Lazarus Krikorian, Svp & Chief Accounting Officer sold 986 shares at $330.96 ($326K).

Trade date
Nov 2, 2026
Disclosed to the SEC
Nov 3, 2026
Type
Pre-planned sale, 10b5-1 (code S)

Read the original SEC filing ↗All COR insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

COR insider transactions (Form 4)

Open-market purchases and sales. 118 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Nov 3SEC Lazarus KrikorianSvp & Chief Accounting Officer Sell Plan 98614,197 held (−6%) $330.96 $326K +3.6% —
Oct 5SEC Lazarus KrikorianSvp & Chief Accounting Officer Sell Plan 98615,183 held (−6%) $303.18 $299K +13.1% —
Sep 17SEC Lon R. GreenbergDirector Sell 1,28017,128 held (−7%) $321.30 $411K +6.8% —
Sep 2SEC Lazarus KrikorianSvp & Chief Accounting Officer Sell Plan 98516,169 held (−6%) $325.97 $321K +5.2% —
Aug 25SEC Elizabeth S. CampbellPresident Sell 11,30019,455 held (−37%) $324.12 $3.7M +5.8% —
Jun 24SEC Lauren M. TylerDirectorFirst buy Buy 5504,359 held (+14%) $270.23 $149K +26.9% —
Jun 22SEC Dermot Mark DurcanDirectorFirst buy in 2 yrsPast buys 2/3 beat S&P Buy 4,00031,767 held (+14%) $274.19 $1.1M +25.1% 75
May 28SEC Dermot Mark DurcanDirectorPast buys 2/3 beat S&P Buy 4,00027,767 held (+17%) $266.26 $1.1M +28.8% 75
Feb 24SEC Robert P. MauchCEO, President Sell Plan 3,76265,393 held (−5%) $358.94 $1.4M -4.4% —
Feb 20SEC Robert P. MauchCEO, President Sell Plan 1,33365,393 held (−2%) $359.46 $479K -4.6% —
Jan 22SEC Robert P. MauchCEO, President Sell Plan 5,09666,726 held (−7%) $354.73 $1.8M -3.3% —
Dec 22SEC Robert P. MauchCEO, President Sell Plan 5,09668,059 held (−7%) $343.45 $1.8M -0.1% —
Dec 22SEC Elizabeth S. CampbellPresident Sell 3,35123,891 held (−12%) $342.10 $1.1M +0.3% —
Dec 22SEC Silvana BattagliaPresident Sell 1,67718,796 held (−8%) $345.00 $579K -0.6% —
Dec 19SEC Lazarus KrikorianSvp & Chief Accounting Officer Sell 4,03117,154 held (−19%) $343.24 $1.4M -0.1% —
Nov 19SEC Robert P. MauchCEO, President Sell Plan 5,09665,746 held (−7%) $366.64 $1.9M -6.4% —
Oct 21SEC Robert P. MauchCEO, President Sell Plan 5,09737,940 held (−12%) $326.80 $1.7M +5.0% —
Oct 3SEC Elizabeth S. CampbellPresident Sell Plan 1,88612,824 held (−13%) $313.28 $591K +9.5% —
Historical context

Similar past setups: not applicable. There aren't enough comparable past cases for COR's latest buying to report odds. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with COR in the Research Lab

Pre-set to COR's latest insider buy of $10K or more (Jun 24, 2026: Dermot Mark Durcan, Lauren M. Tyler, $1.2M). Tap to change anything.

All tools →

Quick backtest: did buys like this beat the market?

Insiders buying
CEO or CFO
Dollar size
Stock before

Tap a setting to see how 6,290 past insider buys did.

Open the full Backtester →

Share price and insider trades

COR closeInsider buyInsider sale
250300350400DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-02-04EEarnings release filed 2026-05-06EEarnings release filed 2026-08-05EEarnings release filed 2026-10-21EEarnings release filed 2026-11-04Bought $148,626 on 2026-06-22 · Lauren M. TylerSold $298,935 on 2026-10-01 · Lazarus KrikorianSold $321,080 on 2026-09-01 · Lazarus KrikorianSold $326,327 on 2026-11-02 · Lazarus KrikorianSold $411,264 on 2026-09-16 · Lon R. GreenbergSold $479,160 on 2026-02-18 · Robert P. MauchBought $1,065,040 on 2026-05-28 · Dermot Mark DurcanBought $1,096,760 on 2026-06-18 · Dermot Mark DurcanSold $1,350,332 on 2026-02-20 · Robert P. MauchSold $1,383,580 on 2025-12-17 · Lazarus KrikorianSold $1,724,942 on 2025-12-19 · Elizabeth S. Campbell, Silvana BattagliaSold $1,750,221 on 2025-12-18 · Robert P. MauchSold $1,807,704 on 2026-01-20 · Robert P. MauchSold $3,662,663 on 2026-08-24 · Elizabeth S. Campbell
Bought, 12 months$2.3M
Sold, 12 months$13.5M
Insiders buying2
Insiders selling5

Cencora insider trading at a glance (Nov 20, 2026): in the past 12 months, 2 insiders bought $2.3M and 5 sold $13.5M of COR stock on the open market; P/E 40.9 vs. a sector median of 25.0.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

COR insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $9.0M sold (7 trades)Q4 2025Q1 2026: $3.6M sold (3 trades)Q1 2026Q2 2026: $2.3M bought (3 trades)$2.3MQ2 2026Q3 2026: $4.4M sold (3 trades)Q3 2026Q4 2026: $625K sold (2 trades)Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0$625K2
Q3 2026—0$4.4M3
Q2 2026$2.3M3—0
Q1 2026—0$3.6M3
Q4 2025—0$9.0M7

Valuation, profit and volume

P/E (trailing)40.9Sector median 25.0
Volume vs. 50-day0.9×Last 5 sessions
Insiders' paper profit+$622KOn all tracked purchases +26.9%

Source: SEC filings, as of Nov 16, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 2 Cencora insiders reported open-market purchases totaling $2.3M, while 5 insiders reported sales totaling $13.5M. Among insiders with enough purchase history to measure, Dermot Mark Durcan (Director) has the highest Insider Score at 75. 10 of 15 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

COR earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Nov 4, 2026 +0.1% Sold $326K -0.2%S&P -2.8% pending
Oct 21, 2026 +8.8% Sold $299K -1.4%S&P -0.7% pending
Aug 5, 2026 +0.8% None +6.1%S&P -0.4% +2.0%
May 6, 2026 -5.3% None -16.4%S&P +1.1% +7.8%
Feb 4, 2026 +1.9% Sold $1.8M -2.7%S&P -1.7% +2.0%
Nov 5, 2025 +5.2% Sold $1.7M +4.6%S&P -0.7% -5.6%
Aug 6, 2025 -0.1% None -4.8%S&P +0.7% +5.3%
May 7, 2025 +3.4% None -2.4%S&P +1.1% +2.0%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

COR short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

20%40%60%2026-08-26: 52% of volume sold short2026-08-27: 38% of volume sold short2026-08-28: 38% of volume sold short2026-08-31: 35% of volume sold short2026-09-01: 47% of volume sold short2026-09-02: 66% of volume sold short2026-09-03: 34% of volume sold short2026-09-04: 48% of volume sold short2026-09-08: 57% of volume sold short2026-09-09: 48% of volume sold short2026-09-10: 49% of volume sold short2026-09-11: 46% of volume sold short2026-09-14: 47% of volume sold short2026-09-15: 53% of volume sold short2026-09-16: 47% of volume sold short2026-09-17: 43% of volume sold short2026-09-18: 39% of volume sold short2026-09-21: 50% of volume sold short2026-09-22: 40% of volume sold short2026-09-23: 38% of volume sold short2026-09-24: 23% of volume sold short2026-09-25: 50% of volume sold short2026-09-28: 34% of volume sold short2026-09-29: 35% of volume sold short2026-09-30: 36% of volume sold short2026-10-01: 43% of volume sold short2026-10-02: 43% of volume sold short2026-10-05: 42% of volume sold short2026-10-06: 42% of volume sold short2026-10-07: 39% of volume sold short2026-10-08: 49% of volume sold short2026-10-09: 54% of volume sold short2026-10-12: 32% of volume sold short2026-10-13: 55% of volume sold short2026-10-14: 45% of volume sold short2026-10-15: 24% of volume sold short2026-10-16: 40% of volume sold short2026-10-19: 37% of volume sold short2026-10-20: 29% of volume sold short2026-10-21: 37% of volume sold short2026-10-22: 33% of volume sold short2026-10-23: 34% of volume sold short2026-10-26: 38% of volume sold short2026-10-27: 44% of volume sold short2026-10-28: 49% of volume sold short2026-10-29: 33% of volume sold short2026-10-30: 32% of volume sold short2026-11-02: 30% of volume sold short2026-11-03: 55% of volume sold short2026-11-04: 59% of volume sold short2026-11-05: 44% of volume sold short2026-11-06: 51% of volume sold short2026-11-09: 49% of volume sold short2026-11-10: 40% of volume sold short2026-11-11: 43% of volume sold short2026-11-12: 36% of volume sold short2026-11-13: 52% of volume sold short2026-11-16: 35% of volume sold short2026-11-17: 27% of volume sold short2026-11-18: 57% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 57%20-day average: 44%Prior 2 months: 42%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Members of Congress who traded COR

From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.

All Congress trades →
MemberTradeTradedReportedSince trade
Alan ArmstrongSenate Bought $1,001 - $15,000 Mar 27, 2026Jul 21, 2026 +10.3%

What happened after COR insiders bought

Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.

Across all stocks →
FiledInsiderBought7 days30 days90 days
Jun 24, 2026Lauren M. TylerDirector$149K +1.4%-0.3% vs S&P+8.9%+8.2% vs S&P+10.7%+5.0% vs S&P
Jun 22, 2026Dermot Mark DurcanDirector$1.1M +3.8%+4.3% vs S&P+10.8%+10.4% vs S&P+16.9%+12.7% vs S&P
May 28, 2026Dermot Mark DurcanDirector$1.1M +1.0%+0.6% vs S&P+5.2%+6.8% vs S&P+22.7%+20.9% vs S&P

Insiders at Cencora

InsiderBoughtSoldLast filingPast buys beat S&PScore
Robert P. MauchCEO, President — $8.9M Nov 13, 2026 — —
Dermot Mark DurcanDirector $2.2M — Jun 22, 2026 2 of 3 75
Elizabeth S. CampbellPresident — $5.4M Nov 13, 2026 — —
Lazarus KrikorianSvp & Chief Accounting Officer — $2.3M Nov 13, 2026 — —
Silvana BattagliaPresident — $579K Jul 7, 2026 1 of 1 —
Lauren M. TylerDirector $149K — Nov 3, 2026 1 of 1 —
Lon R. GreenbergDirector — $411K Sep 17, 2026 — —
Pawan VermaEvp, Chief Data & Info Officer — — Nov 13, 2026 — —
Dennis M. NallyDirector — — Nov 3, 2026 — —
Ellen CooperDirector — — Nov 3, 2026 — —
Robert E. SanchezDirector — — Oct 5, 2026 — —
James F. ClearyCFO — — Mar 13, 2026 — —
Lori RyerkerkDirector — — Mar 9, 2026 — —
Lorence H. KimDirector — — Mar 9, 2026 — —
Frank ClyburnDirector — — Mar 9, 2026 — —
Redonda MillerDirector — — Mar 9, 2026 — —
Werner BaumannDirector — — Mar 9, 2026 — —

Board links: companies that share insiders with COR

Directors and executives who filed Form 4s for COR and another company in the last 12 months.

See the map →
  • CNCCentene Lauren M. Tyler Director here · Director at CNC · latest filing Nov 3, 2026
  • ETNEaton Lori Ryerkerk Director here · Director at ETN · latest filing May 8, 2026
  • MSMorgan Stanley Dennis M. Nally Director here · Director at MS · latest filing Nov 3, 2026
  • RRyder System Robert E. Sanchez Director here · Chair at R · latest filing Oct 28, 2026
  • RVMDRevolution Medicines Lorence H. Kim Director here · Director at RVMD · latest filing Sep 10, 2026
  • TXNTexas Instruments Robert E. Sanchez Director here · Director at TXN · latest filing Oct 29, 2026

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

COR stock: common questions

Are Cencora insiders buying COR stock?

In the past 12 months, 2 insiders reported open-market purchases of COR worth $2.3M. The latest was Director Lauren M Tyler bought $149K of COR at $270.23 — first open-market purchase in our records.

Are Cencora insiders selling COR stock?

5 insiders reported sales worth $13.5M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is COR's P/E ratio?

COR trades at about 40.9 times trailing earnings, compared with a median of 25.0 for the Health Care sector.

What is COR's 52-week range?

Over the past year COR has traded between $251.67 and $372.53. It last closed at $343.02 on Nov 20, 2026.